» Authors » Mohammad Sadeghi

Mohammad Sadeghi

Explore the profile of Mohammad Sadeghi including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 54
Citations 195
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Songhori N, Goushky M, Khaleghi M, Mojerloo M, Sadeghi M, Mozafar M, et al.
Health Sci Rep . 2025 Mar; 8(3):e70534. PMID: 40078900
Background And Aims: Alzheimer's disease (AD) is a widespread neurodegenerative condition that has a growing impact on a global scale. This study aims to examine the relationship between cerebral blood...
2.
Niknam N, Khaefi S, Heidarpour H, Sadeghi M, Jafari N, Mohammadi S, et al.
J Clin Neurosci . 2025 Feb; 135:111141. PMID: 40010169
Diffusion tensor imaging (DTI) can be used to detect early signs of increased water diffusivity in white matter tracts in patients with mild cognitive impairment (MCI). This study examined how...
3.
Sameni F, Elkhichi P, Dadashi A, Sadeghi M, Goudarzi M, Eshkalak M, et al.
BMC Gastroenterol . 2025 Feb; 25(1):71. PMID: 39930345
Background: Colorectal cancer (CRC) is the second deadliest carcinoma across the globe and has been known as a multi-factor induced-disease. Emerging research have demonstrated that bacterial colonization may contribute to...
4.
Mir M, Khosravani P, Ramezannezhad E, Saadabad F, Falahati M, Ghanbarian M, et al.
Curr Alzheimer Res . 2025 Jan; PMID: 39878109
Background: Alzheimer's disease (AD) is a progressive neurodegenerative condition with rising prevalence due to the aging global population. Existing methods for diagnosing AD are struggling to detect the condition in...
5.
Daneshpour A, Nasiri H, Motamed A, Heidarzadeh N, Moghadam Fard A, Koleini S, et al.
Neurol Sci . 2025 Jan; PMID: 39838256
Background: Alzheimer's disease (AD) is a progressive neurodegenerative disorder ranging from mild cognitive impairment (MCI) to AD dementia. Abnormal cerebral perfusion alterations, influenced by amyloid-beta (Aβ) accumulations, have been implicated...
6.
Ghaemi M, Sadeghi M, Kafi M, Pakniat Z
Vet Res Commun . 2024 Dec; 49(1):51. PMID: 39676084
A remarkable percentage of cows in industrialized dairy farms can be affected by uterine diseases including endometritis. Different viral and bacterial agents are causing endometritis in dairy cows including Trueperella...
7.
Nasiri H, Azaraein M, Shakeri S, Sadeghi M, Sohrabi-Ashlaghi A, Berenjian S, et al.
Arch Gerontol Geriatr . 2024 Dec; 130():105703. PMID: 39631103
Introduction: Blood-based biomarkers such as plasma neurofilament light chain (pNfL) are crucial biomarkers for Alzheimer's disease (AD). Additionally, neuroimaging techniques such as tensor-based morphometry (TBM), which identify structural changes in...
8.
Ariaei A, Ghorbani A, Habibzadeh E, Moghaddam N, Chegeni Nezhad N, Abdoli A, et al.
BMC Neurol . 2024 Oct; 24(1):397. PMID: 39420261
Background: Synaptic degeneration, axonal injury, and white matter disintegration are among the pathological events in Alzheimer's disease (AD), for which growth-associated protein 43 (GAP-43) and diffusion tensor imaging (DTI) could...
9.
Sadeghi M, Azargoonjahromi A, Nasiri H, Yaghoobi A, Sadeghi M, Chavoshi S, et al.
Mol Brain . 2024 Aug; 17(1):60. PMID: 39215335
Mild Cognitive Impairment (MCI) is a neurological condition characterized by a noticeable decline in cognitive abilities that falls between normal aging and dementia. Along with some biomarkers like GAP-43, Aβ,...
10.
Farhadieh M, Mozafar M, Sanaaee S, Sodeifi P, Kousha K, Zare Y, et al.
Arch Gerontol Geriatr . 2024 Aug; 127:105576. PMID: 39096557
Background: Growth associated protein-43 (GAP-43) and neurofilaments light (NFL) are biomarkers of synaptic and axonal injury, and are associated with cognitive decline in Alzheimer's disease (AD) contiuum. We investigated whether...